KR20070085727A - 인다졸 화합물의 제조 방법 - Google Patents

인다졸 화합물의 제조 방법 Download PDF

Info

Publication number
KR20070085727A
KR20070085727A KR1020077012588A KR20077012588A KR20070085727A KR 20070085727 A KR20070085727 A KR 20070085727A KR 1020077012588 A KR1020077012588 A KR 1020077012588A KR 20077012588 A KR20077012588 A KR 20077012588A KR 20070085727 A KR20070085727 A KR 20070085727A
Authority
KR
South Korea
Prior art keywords
formula
compound
alkyl
substituted
aryl
Prior art date
Application number
KR1020077012588A
Other languages
English (en)
Korean (ko)
Inventor
스리니바산 바부
레이몬드 쥬니어 다그니노
아우브레이 하다치
마크 브리안 미첼
마이클 알렌 오우엘레트
제임스 에드워드 사엔즈
자야람 카츄리 스리랑감
슈 유
스코트 에드워드 주크
Original Assignee
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 인코포레이티드 filed Critical 화이자 인코포레이티드
Publication of KR20070085727A publication Critical patent/KR20070085727A/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR1020077012588A 2004-11-02 2005-10-21 인다졸 화합물의 제조 방법 KR20070085727A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62471904P 2004-11-02 2004-11-02
US60/624,719 2004-11-02
US62480104P 2004-12-14 2004-12-14
US60/624,801 2004-12-14

Publications (1)

Publication Number Publication Date
KR20070085727A true KR20070085727A (ko) 2007-08-27

Family

ID=35456957

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077012588A KR20070085727A (ko) 2004-11-02 2005-10-21 인다졸 화합물의 제조 방법

Country Status (9)

Country Link
EP (1) EP1814859A2 (fr)
KR (1) KR20070085727A (fr)
AU (1) AU2005300241A1 (fr)
CA (1) CA2591313A1 (fr)
IL (1) IL183605A0 (fr)
MX (1) MX2007006554A (fr)
RU (1) RU2007120635A (fr)
TW (1) TW200630345A (fr)
WO (1) WO2006048761A2 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2136284A1 (en) * 1971-02-08 1972-08-31 Diamond Shamrock Corp., Cleveland, Ohio (V.StA.) Herbicidal pyrrolidinyl-carboxanilides - from arylisocyanates and pyrrolidines in organic solvents
PE20010306A1 (es) * 1999-07-02 2001-03-29 Agouron Pharma Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa

Also Published As

Publication number Publication date
WO2006048761A3 (fr) 2006-06-22
AU2005300241A2 (en) 2006-05-11
WO2006048761A2 (fr) 2006-05-11
AU2005300241A1 (en) 2006-05-11
MX2007006554A (es) 2007-06-19
IL183605A0 (en) 2007-09-20
EP1814859A2 (fr) 2007-08-08
RU2007120635A (ru) 2008-12-10
TW200630345A (en) 2006-09-01
CA2591313A1 (fr) 2006-05-11

Similar Documents

Publication Publication Date Title
JP2008518901A (ja) インダゾール化合物を調製するための方法
CN101094836A (zh) 制备吲唑化合物的方法
JP2014516072A (ja) アピキサバン製造方法
KR20070058690A (ko) 인다졸 화합물의 제조방법
IL197527A (en) History - 4-Oxoquoquinoline and Process and Intermediate Compounds for Preparation of Integration Inhibitors
JP4820295B2 (ja) イソインドール誘導体の製造方法
CZ2016627A3 (cs) Způsob přípravy (7-fenoxy-4-hydroxy-1-methylisochinolin-3-karbonyl)glycinu (roxadustatu) a jeho intermediátů založený na souběžném otevírání oxazolového kruhu, štěpení etheru a tvorbě iminu
KR20100103646A (ko) ６­치환된­１­（２ｈ）­이소퀴놀리논의 제조 방법
EP3589606B1 (fr) Protodécarboxylation à catalyse par métal de transition de dérivés d'acide alpha-halo-acrylique
JP2024054201A (ja) １－［（３ｒ，４ｓ）－４－シアノテトラヒドロピラン－３－イル］－３－［（２－フルオロ－６－メトキシ－４－ピリジル）アミノ］ピラゾール－４－カルボキサミドの調製方法
JPH0479349B2 (fr)
SK281250B6 (sk) Spôsob výroby látok antagonizujúcich receptory fibrinogénu a látky antagonizujúce receptory fibrinogénu
JP5017101B2 (ja) 不斉四置換炭素原子含有化合物の製法
AU594858B2 (en) Process and intermediates for quinolonecarboxylic acid
KR20070085727A (ko) 인다졸 화합물의 제조 방법
KR20050060061A (ko) 졸미트립탄 화합물의 제조방법
CZ304984B6 (cs) Zlepšený způsob výroby a nové intermediáty syntézy elvitegraviru
CZ614690A3 (en) 3-methoxy-4-£1-methyl-5-(2-methyl-4,4,4-trifluorobutylcarbamoyl) indol-3-ylmethyl|-n-(2-methylphenylsulfonyl)benzamide, pharmaceutically acceptable salt thereof, process of their preparation and pharmaceutical compositions containing thereof
JP5073497B2 (ja) テトラ置換−５−アザスピロ［２．４］へプタン誘導体の製法およびその光学活性中間体
WO2008032702A1 (fr) Composé de fluorobore ayant un noyau aromatique ou sel de celui-ci, et procédé de fabrication du composé ayant un noyau aromatique fusionné à un éther cyclique à l'aide de celui-ci
US20020077331A1 (en) Synthesis of intermediates useful in preparing tricyclic compounds
CA3223714A1 (fr) Procede de preparation d?un inhibiteur de cyp11a1 et de ses intermediaires
WO2000030589A2 (fr) Synthese d'intermediaires utiles a la preparation de composes tricycliques
KR20190110400A (ko) 새로운 중간체를 이용한 바제독시펜의 제조방법
EA040460B1 (ru) ПРОТОДЕКАРБОКСИЛИРОВАНИЕ ПРОИЗВОДНЫХ α-ГАЛОГЕНАКРИЛОВОЙ КИСЛОТЫ, КАТАЛИЗИРУЕМОЕ ПЕРЕХОДНЫМ МЕТАЛЛОМ

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application